908 Devices Inc (MASS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
908 Devices Inc stock (MASS) is currently trading at $6.32. 908 Devices Inc PS ratio (Price-to-Sales) is 4.06. Analyst consensus price target for MASS is $10.00. WallStSmart rates MASS as Sell.
- MASS PE ratio analysis and historical PE chart
- MASS PS ratio (Price-to-Sales) history and trend
- MASS intrinsic value — DCF, Graham Number, EPV models
- MASS stock price prediction 2025 2026 2027 2028 2029 2030
- MASS fair value vs current price
- MASS insider transactions and insider buying
- Is MASS undervalued or overvalued?
- 908 Devices Inc financial analysis — revenue, earnings, cash flow
- MASS Piotroski F-Score and Altman Z-Score
- MASS analyst price target and Smart Rating
908 Devices Inc
📊 No data available
Try selecting a different time range
Smart Analysis
908 Devices Inc (MASS) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book, profit margin, institutional own.. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
908 Devices Inc (MASS) Key Strengths (3)
Keeps $35 of every $100 in revenue as net profit
87.09% of shares held by major funds and institutions
Trading at 1.59x book value, attractively priced
Supporting Valuation Data
908 Devices Inc (MASS) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Revenue declining -7.70%, a shrinking business
Micro-cap company with very limited liquidity and high volatility
Premium valuation at 4.1x annual revenue
908 Devices Inc (MASS) Detailed Analysis Report
Overall Assessment
This company scores 35/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 3 register as strengths (avg 9.3/10) while 5 fall into concern territory (avg 1.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Profit Margin, Institutional Own., Price/Book. Valuation metrics including Price/Book (1.59) suggest the stock is attractively priced. Profitability is solid with Profit Margin at 34.70%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Sales (4.06) suggest expensive pricing. Growth concerns include Revenue Growth at -7.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -25.80%, Operating Margin at -17.30%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -25.80% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -7.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
MASS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
MASS's Price-to-Sales ratio of 4.06x trades at a deep discount to its historical average of 15.13x (31th percentile). The current valuation is 95% below its historical high of 76.64x set in Dec 2020, and 199% above its historical low of 1.36x in Feb 2025. Over the past 12 months, the PS ratio has expanded from ~2.5x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for 908 Devices Inc (MASS) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
908 Devices Inc faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 56M with 8% decline year-over-year. Profit margins are strong at 34.7%, reflecting pricing power and operational efficiency.
Key Findings
Generating 1M in free cash flow and 1M in operating cash flow. Earnings are translating into actual cash generation.
Debt-to-equity ratio of 0.03 indicates a conservative balance sheet with 63M in cash.
Revenue contracted 8% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact 908 Devices Inc.
Bottom Line
908 Devices Inc faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About 908 Devices Inc(MASS)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
908 Devices Inc. develops and sells measuring devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Boston, Massachusetts.